A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide
Clinical trial NCT03289741 · COMPLETED
Trial details
- NCT number
- NCT03289741
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-19
- Primary completion
- 2023-04-10
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.